3dMD
Showing 1 - 25 of 812
Development, Infant, IMAGE, Craniofacial Asymmetry Trial in Taoyuan (three dimensional photography using a 3dMDHead System
Completed
- Development, Infant
- +3 more
- three dimensional photography using a 3dMDHead System (3dMD, Atlanta, GA, USA)
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Aug 6, 2021
Duchenne Muscular Dystrophy Trial in Vancouver (Vamorolone)
Recruiting
- Duchenne Muscular Dystrophy
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital
Mar 24, 2022
Wearable Technology to Assess Gait Function in SMA and DMD
Recruiting
- Spinal Muscular Atrophy Type 3
- Duchenne Muscular Dystrophy
-
New York, New YorkColumbia University Medical Center
Mar 7, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen)
Enrolling by invitation
- Duchenne Muscular Dystrophy
-
Westmead, Australia
- +13 more
May 24, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Vamorolone, Prednisone, Placebo)
Duchenne Muscular Dystrophy Trial in United States (SRP-9001, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- SRP-9001
- Placebo
-
Little Rock, Arkansas
- +13 more
May 19, 2023
Duchenne Muscular Dystrophy Trial in Worldwide (SRP-9001, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- SRP-9001
- Placebo
-
Sacramento, California
- +9 more
Mar 10, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Pamrevlumab, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- Pamrevlumab
- Placebo
-
Little Rock, Arkansas
- +46 more
Apr 11, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Vamorolone 0.25 mg/day/day, Vamorolone 0.75 mg/day/day, Vamorolone 2.0
Completed
- Duchenne Muscular Dystrophy
- Vamorolone 0.25 mg/day/day
- +3 more
-
Davis, California
- +11 more
Apr 28, 2021
Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- Viltolarsen
- Placebo
-
Sacramento, California
- +38 more
May 23, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Pamrevlumab, Placebo)
Active, not recruiting
- Duchenne Muscular Dystrophy
- Pamrevlumab
- Placebo
-
Little Rock, Arkansas
- +52 more
Jan 21, 2022
Pain, Postoperative Trial in Kayseri (iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, Istanbul, Turkey), Steril Salin
Completed
- Pain, Postoperative
- iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, İstanbul, Turkey)
- Steril Salin (control)
-
Kayseri, Melikgazi, TurkeyYusuf Nuri Kaba
Mar 28, 2022
Muscular Dystrophy (DMD) Trial in Canada, United States (RO7239361, Placebo)
Duchenne Muscular Dystrophy (DMD) Trial in Worldwide (Idebenone 150 mg film-coated tablets, )
Terminated
- Duchenne Muscular Dystrophy (DMD)
- Idebenone 150 mg film-coated tablets
- placebo
-
Birmingham, Alabama
- +62 more
Nov 24, 2021
Duchenne Muscular Dystrophy Trial in Worldwide (SRP-4045, SRP-4053, Placebo)
Active, not recruiting
- Duchenne Muscular Dystrophy
- SRP-4045
- +2 more
-
Phoenix, Arizona
- +74 more
Jan 17, 2023
Duchenne Muscular Dystrophy Trial in Worldwide (Placebo, SRP-4053)
Duchenne Muscular Dystrophy Trial in Worldwide (Givinostat)
Enrolling by invitation
- Duchenne Muscular Dystrophy
-
Sacramento, California
- +38 more
Mar 3, 2022
Postoperative Edema and Pain Trial in Boston (ActiPatch(TM), Placebo)
Terminated
- Postoperative Edema and Pain
- ActiPatch(TM)
- Placebo
-
Boston, MassachusettsTufts University School of Dental Medicine Department of Oral an
Oct 1, 2021
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
Not yet recruiting
- Duchenne Muscular Dystrophy
- wearable technology
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 3, 2023
Duchenne Muscular Dystrophy Trial in Ankara (telerehabilitation-based motor imagery training, telerehabilitation-based
Not yet recruiting
- Duchenne Muscular Dystrophy
- telerehabilitation-based motor imagery training
- telerehabilitation-based physiotheraphy training
-
Ankara, TurkeyHacettepe University
Oct 27, 2023
Duchenne Muscular Dystrophy With Small Mutations
Recruiting
- Muscular Dystrophy, Duchenne
- MUSCLE MAGNETIC RESONANCE IMAGING (MRI)
-
Rome, ItalyClaudia Brogna
Apr 17, 2023
Hyperglycemia and HRV in DMD - Longitudinal Aim
Not yet recruiting
- Duchenne Muscular Dystrophy
- wearable technology
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 16, 2023